Author

Soetkin D'haens 1

1 Imelda GI Clinical Research Center,Bonheiden,Belgium

ULTRAPROACTIVE THERAPEUTIC DRUG MONITORING BASED ON POINT-OF-CARE TESTING OF INFLIXIMAB IS NOT SUPERIOR TO REACTIVE DRUG MONITORING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: 1 YEAR RESULTS OF A PRAGMATIC CLINICAL TRIAL

Peter Bossuyt, Sophie Claeys, Soetkin D'haens, Eveline Hoefkens, Beatrijs Strubbe, Denis Marichal, Lieven Pouillon, Harald Peeters

Item 1 - 1 / 1
1